Target intelligence / Profile preview

Nerve to vastus lateralis muscle (NVL)

Target
NVL
Molecular classification
Other
01

Overview

The Nerve to vastus lateralis muscle (NVL) is a major motor branch of the femoral nerve, arising from the L2 through L4 spinal nerve roots. Its primary biological function is to provide the essential motor innervation required for the contraction of the vastus lateralis, the largest muscle of the quadriceps femoris group, which facilitates knee extension and joint stability. Anatomically, the NVL often follows a predictable course alongside the descending branch of the lateral circumflex femoral artery, typically dividing into multiple terminal branches before entering the muscle belly. While it is an anatomical structure rather than a molecular receptor, the NVL is a significant clinical target for regional anesthesia and ultrasound-guided nerve blocks, particularly in the management of postoperative pain following knee or hip arthroplasty. Selective blockade of this nerve is frequently studied for its potential to provide targeted analgesia while sparing more significant motor functions compared to a proximal femoral nerve block. However, iatrogenic injury to the NVL during surgical procedures, such as anterolateral thigh flap harvests or femoral fracture repairs, can lead to muscle atrophy and significant functional impairment in lower limb mobility.

Other names
NVLMuscular branch of femoral nerve to vastus lateralisVastus lateralis nerveNervus vasti lateralis
02

Mechanism of action

Sodium channel blockade (via local anesthetics)

03

Biological functions

Motor innervation of the vastus lateralis muscleSomatic motor controlKnee extensionProprioception
04

Disease associations

Femoral neuropathyMuscle atrophyIatrogenic nerve injuryPostoperative painQuadriceps weakness
05

Safety considerations

Iatrogenic nerve damage during surgeryLocal anesthetic systemic toxicity (LAST)Persistent muscle denervationMotor weakness leading to fallsAccidental intravascular injection
06

Interacting drugs

Lidocaine

4 more in the full profile.

07

Biomarkers

Compound muscle action potential (cMAP)Electromyography (EMG)Nerve conduction velocityMaximum voluntary isometric contraction (MVIC)

Beyond the preview

Go deeper on Nerve to vastus lateralis muscle (NVL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nerve to vastus lateralis muscle (NVL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call